CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in IOVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,770,892
+$2,254,266 QoQ
Shares Held
2,783,730
+1.1% QoQ
Ownership
0.623%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. IOVA ranks #98 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in IOVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,770,892 | 2,783,730 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,516,626 | 2,753,343 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,434,856 | 2,504,542 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,296,355 | 1,916,486 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,152,977 | 1,847,741 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $14,721,116 | 1,989,340 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $17,964,422 | 1,913,144 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $15,919,258 | 1,984,945 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $28,352,142 | 1,913,100 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $14,203,296 | 1,747,023 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,701,025 | 1,692,533 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $10,498,202 | 1,491,222 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,451,255 | 1,055,852 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,740,453 | 1,054,844 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,843,066 | 1,027,460 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,045,210 | 1,000,472 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,779,808 | 707,496 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,085,412 | 685,459 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $16,420,995 | 665,896 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $19,655,924 | 755,416 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $22,436,112 | 708,658 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $30,125,524 | 649,257 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $21,031,600 | 638,870 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $17,169,618 | 625,487 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $22,224,761 | 742,310 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||